A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis

Pediatric Allergy and Immunology

Volumn 23, Issue 7, 2012, Pages 667-673

  Han, Youngshin ^a,b   Kim, Bongjoon ^c   Ban, Jeongsook ^b   Lee, Jeongok ^b   Kim, Beom Joon ^d   Choi, Byung Sun ^d   Hwang, Sehee ^c   Ahn, Kangmo ^a,b   Kim, Jihyun ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c CJ Corporation   (South Korea)

^d Chung Ang University   (South Korea)

Author keywords

Atopic dermatitis; Lactobacillus plantarum; Probiotics

Indexed keywords

CJLP133; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 4; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHIL COUNT; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LACTOBACILLUS PLANTARUM; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; INFANT; INTERFERON-GAMMA; INTERLEUKIN-4; LACTOBACILLUS PLANTARUM; MALE; PROBIOTICS; TREATMENT OUTCOME;

EID: 84868205297     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12010     Document Type: Article

References (30)

1. van der Aa LB, Heymans HS, van Aalderen WM, Sprikkelman AB. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr Allergy Immunol 2010: 21: e355-67.
2. Pan SJ, Kuo CH, Lam KP, Chu YT, Wang WL, Hung CH. Probiotics and allergy in children-an update review. Pediatr Allergy Immunol 2010: 21: e659-66.
3. Lewis MC, Inman CF, Patel D, et al. Direct experimental evidence that early-life farm environment influences regulation of immune responses. Pediatr Allergy Immunol 2012: 23: 265-9.
4. Bjorksten B. Environment and infant immunity. Proc Nutr Soc 1999: 58: 729-32.
5. Kirjavainen PV, Gibson GR. Healthy gut microflora and allergy: factors influencing development of the microbiota. Ann Med 1999: 31: 288-92.
6. Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Robins-Browne RM, Tang ML. Prenatal administration of Lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota. Pediatr Allergy Immunol 2012: 23: 255-8.
7. Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005: 90: 892-7.
8. Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 2010: 11: 351-61.
9. Woo SI, Kim JY, Lee YJ, Kim NS, Hahn YS. Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Ann Allergy Asthma Immunol 2010: 104: 343-8.
10. Brouwer ML, Wolt-Plompen SA, Dubois AE, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006: 36: 899-906.
11. Gruber C, Wendt M, Sulser C, et al. Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 2007: 62: 1270-6.
12. Kim JY, Kwon JH, Ahn SH, et al. Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010: 21: e386-93.
13. Passeron T, Lacour JP, Fontas E, Ortonne JP. Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006: 61: 431-7.
14. Won TJ, Kim B, Lim YT, et al. Oral administration of Lactobacillus strains from Kimchi inhibits atopic dermatitis in NC/Nga mice. J Appl Microbiol 2011: 110: 1195-202.
15. Kang H, Oh YJ, Ahn KS, et al. Leuconostoc citreum HJ-P4 (KACC 91035) regulates immunoglobulin E in an ovalbumin-induced allergy model and induces interleukin-12 through nuclear factor-kappa B and p38/c-Jun N-terminal kinases signaling in macrophages. Microbiol Immunol 2009: 53: 331-9.
16. Lee J, Yun HS, Cho KW, et al. Evaluation of probiotic characteristics of newly isolated Lactobacillus spp.: immune modulation and longevity. Int J Food Microbiol 2011: 148: 80-6.
17. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980: 1980: 44-7.
18. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993: 186: 23-31.
19. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet 1999: 354 (Suppl 2): SII12-5.
20. Yao TC, Chang CJ, Hsu YH, Huang JL. Probiotics for allergic diseases: realities and myths. Pediatr Allergy Immunol 2010: 21: 900-19.
21. Singh M, Ranjan Das R. Probiotics for allergic respiratory diseases-putting it into perspective. Pediatr Allergy Immunol 2010: 21: e368-76.
22. Wu KG, Li TH, Chen CJ, Cheng HI, Wang TY. Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis. Int J Immunopathol Pharmacol 2011: 24: 15-23.
23. Trautmann A, Akdis M, Kleemann D, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest 2000: 106: 25-35.
24. Novak N, Leung DY. Advances in atopic dermatitis. Curr Opin Immunol 2011: 23: 778-83.
25. Akdis CA, Akdis M, Bieber T, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006: 61: 969-87.
26. Bieber T. Atopic dermatitis. N Engl J Med 2008: 358: 1483-94.
27. Smits HH, Engering A, van der Kleij D, et al. Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J Allergy Clin Immunol 2005: 115: 1260-7.
28. Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 2002: 109: 119-21.
29. Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y. Supernatant of Bifidobacterium breve induces dendritic cell maturation, activation, and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol 2006: 117: 696-702.
30. Kwon HK, Lee CG, So JS, et al. Generation of regulatory dendritic cells and CD4+ Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci USA 2010: 107: 2159-64.